MS Center of Northeastern New York   Report issue

Academic/Hospital Phase 1 Phase 4
Founded: New York NY United States

Organization Overview

First Clinical Trial
2012
NCT01764737
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

MS Center of Northeastern NY | MS Center of Northeastern NY/Empire Neurology | Multiple Sclerosis Center of Northeastern New York